William R. Bensch

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.

Larry J. Black, Masahiko Sato, Ellen R. Rowley et al. · Journal of Clinical Investigation · 1994 · 613 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis

Yuewei Qian, Robert J. Schmidt, Youyan Zhang et al. · Journal of Lipid Research · 2007 · 233 citations · Full text

Life Sciences, Cell Biology, Cell Signaling +16

Identification and Characterization of a Major Liver Lysophosphatidylcholine Acyltransferase

Yang Zhao, Yan Chen, Tabetha M. Bonacci et al. · Journal of Biological Chemistry · 2008 · 197 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo

Guoqing Cao, Thomas P. Beyer, Xiao Yang et al. · Journal of Biological Chemistry · 2002 · 184 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Deficiency of Adiponectin Receptor 2 Reduces Diet-Induced Insulin Resistance but Promotes Type 2 Diabetes

Yanfang Liu, M. Dodson Michael, Shera Kash et al. · Endocrinology · 2006 · 114 citations

Medicine, Endocrinology, Physiology +17